Cannabis Sativa, Inc. (CBDS)
| Market Cap | 14.51M |
| Revenue (ttm) | 2.10M |
| Net Income (ttm) | -2.00M |
| Shares Out | 27.99M |
| EPS (ttm) | -0.08 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | June 22 |
| Last Price | $0.5049 |
| Previous Close | $0.5000 |
| Change ($) | 0.0049 |
| Change (%) | 0.98% |
| Day's Open | 0.5200 |
| Day's Range | 0.4600 - 0.5200 |
| Day's Volume | 23,860 |
| 52-Week Range | 0.3200 - 1.2500 |
News
There are no news available yet.
About CBDS
Cannabis Sativa, Inc., through its subsidiaries, primarily provides telemedicine online referral services for customers desiring medical marijuana cards in the United States. It operates through two segments, PrestoCorp and GKMP. The company offers PrestoDoctor, an online telemedicine platform, which provides access to physicians for getting a medical marijuana recommendation using video conferencing technology; and operates as a contract manufacturer of products containing hemp-based cannabidiol (CBD). Its products under development include Re... [Read more...]
| Industry Drug Manufacturers-Specialty & Generic | |
| CEO David Tobias | Country United States |
| Stock Exchange OTCMKTS | Ticker Symbol CBDS |
Financial Performance
In 2020, CBDS's revenue was $2.04 million, an increase of 75.50% compared to the previous year's $1.16 million. Losses were -$2.17 million, -44.79% less than in 2019.